Lumenis Optilight

OptiLIGHT is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases. The treatment addresses inflammation, which is one of the key underlying factors in MGD. OptiLIGHT was specifically developed to reach the delicate contours of the treated area safely, effectively, and gently using the OPT™ technology. It is intended for use in patients who are at least 22 years old, together with other available treatments, such as Meibomian gland expression, artificial tear lubricants, and warm compresses.

Had enough of dry, itchy eyes? Meet OptiLIGHT, a real solution for dry eye disease arising from MGD (Meibomian Gland Dysfunction), the foremost cause behind this condition. Utilizing patented OPT™ technology, OptiLIGHT is a light-based treatment thoughtfully designed to reach even the most delicate treatment areas, ensuring an experience that is safe, precise and gentle.

Ready to give your dry eyes the real solution they deserve? Your journey to a brighter future with OptiLIGHT starts by contacting us today.